Introduction
Breast cancer in women is among the malignancies with the highest incidence and mortality in high-income countries such Switzerland [1] . More than 5700 women are affected in Switzerland each year, and 1400 die from breast cancer each year [1] . It is therefore a major public health problem. European and international associations recommend mammography screening of women aged 50 to 70 years for early detection of breast cancer [2] . Screening aims at detecting cancer or its precursor lesions early, when they are in a curable state. However, the value of screening programmes is a matter of debate because of the limited effect on mortality, false-positive findings requiring diagnostic workup and possible overdiagnosis and overtreatment [3] [4] [5] [6] [7] . In Switzerland, screening attendance is higher in the French-speaking area (mainly screening programmes) than in the German-speaking (mainly opportunistic screening) [8, 9] , and this difference does not appear to be explained by sociodemographic or health-related factors [9] . Uptake of breast cancer screening has also been reported to be increased in women with higher incomes [10] . In 1995, the Swiss Federal Office of Public Health and the Swiss Cancer League adopted a national strategy for prevention, screening and care for breast cancer. Although a national screening programme has repeatedly been suggested in subsequent national strategy reports, a national programme has not been established [11] , and Swiss cantons may or may not put a programme in place. Swiss compulsory basic health insurance reimburses mammography screening without access payments for women aged 50 to 70 years (at average risk), if carried out within a cantonal screening programme with systematic invitation of women and quality control of the screening process. Breast cancer screening attendance was expected to change after cantonal mammography programmes were expanded over time. Up to 2012, 9 out of 26 cantons introduced mammography screening, 5 after 2005 [1] . We aimed to study time trends and associations of sociodemographic characteristics and health-related factors with the changes of breast cancer screening in Switzerland between 2007 and 2012, using data from the nationwide representative health surveys.
Methods

Survey sample
The Swiss Health Interview Survey (SHIS) is a cross-sectional survey conducted every five years since 1992 by the Swiss Federal Statistical Office (SFSO). A random multistage probability sample is drawn from all residents in Switzerland, as previously reported [8, 12, 13] . The health survey collects data through computer-assisted telephone interviews (oral) and self-administered questionnaires (written). The interviews are conducted in the three official languages (German, French and Italian). In this study, we analysed the two most recent available data sets (from 2007 and 2012). We included 11,292 female respondents aged 40 to 79 years who responded to a written questionnaire, 5123 in 2007 and 6169 in 2012.
Data collection
The main questions on breast cancer detection were: -Have you already had mammography? (yes, no, unknown); -When was the mammography done last time? (date, if unknown: last 12 months, yes/no); -Who initiated the last mammography? (initiated by the woman or a physician, invitation by a mammography screening program, unknown); and -What was the reason for the last mammography? (preventive examination/check-up without clinical symptoms, diagnostic workup, follow-up evaluation, unknown).
Additional data collected included sociodemographic, socioeconomic and health-related information, citizenship, screening for colon cancer (Haemoccult, endoscopy), and type of hospital stay insurance (basic, semiprivate, private, other). Regional availability of breast cancer screening programmes during the study period was defined as follows: cantons with long-standing programmes established before 2005, cantons who introduced a programme after 2005 and cantons without a programme [14] .
Statistical analysis
For each survey year 2007 and 2012, we calculated the proportions of the female population reporting having mammography in the last 12 months, the proportion of mammography as part of a screening programme (programmatic mammography) and the proportion of screening mammography initiated by the woman or a physician (opportunistic mammography). We used univariate and multivariate logistic regression models to calculate unadjusted and adjusted odds ratios (aORs), with the following outcome variables: mammography in the last 12 months versus not done, programmatic versus non-programmatic mammography (last mammography), and opportunistic vs. all other mammography (last mammography). An interaction term with the year of survey and the variable of interest was also included. In all analyses, we used the survey weights provided by the SFSO, and reported all proportions and ORs with the corresponding 95% confidence in- (table 1) . We also observed regional differences: the French-speaking area and the southern part of Switzerland had a higher rate of self-reported mammography, as did regions with a long-standing cantonal screening programme. A lower rate of self-reported mammography was observed in the German-speaking area of Switzerland and in regions with no or recently introduced screening programmes. The regional differences in the use of any mammography in the last 12 months are shown in figure 1 , and the use of opportunistic and programmatic mammography in supplementary figure S2. 
Discussion
We analysed data from two representative, nationwide health surveys in Switzerland. We found that the self-reported use of mammography among women aged 40 to 79 years in Switzerland declined from 19% in 2007 to 12% in 2012. The use of opportunistic mammography in the last 12 months dropped from 12.0 to 6.2%, whereas the use of programmatic screening mammography remained stable at 3.1%. Proportionally, the use of programmatic screening increased. There were also regional differences in the use of mammography. In Switzerland and other countries, mammography screening is recommended for women aged between 50 and 69 years every 2 years [2] . The reported use of mammography in the last 12 months by approximately 20% of women aged 50 to 69 years would correspond to around 40% in the recommended time interval of 2 years. This is relatively low compared with other European countries, where screening rates range from 23% in the Slovak Republic to over 80% in Portugal, Denmark, Finland and Slovenia in 2014 [15] . The European Guidelines suggest a target screening rate of >75% among eligible women aged 50 to 70 years [2] . We also found that overall the use of mammography declined from 19% in 2007 to 12% in 2012. This decline might reflect the ongoing debate about the benefits (mortality) and harms (false-positive results requiring diagnostic workup, overdiagnosis, overtreatment) of breast cancer screening [3, [5] [6] [7] 16] , and the increasing emphasis that is put on ensuring informed decision making [4] . It has been shown that the level of information of the public appears to strongly influence willingness to participate in screening programmes [17] . Indeed, the positive effects of breast cancer screening were initially overestimated by women in Switzerland and elsewhere [18] , but this may have changed over time to a more critical public view on breast cancer screening. In absolute numbers, opportunistic screening mammography in the last 12 months halved between 2007 and 2012 (12 to 6%), while programmatic screening remained stable at a low level (3%) overall, but tended to decrease in regions with a long-standing programme and increase in regions with a recently introduced programme. Proportionally, programmatic screening mammography increased during the study period, while opportunistic screening decreased. These findings suggest at least a temporarily positive effect of the established cantonal screening programmes, particularly in more recently introduced programmes, but also suggests a shift from individual screening to cantonal programmes. Screening programmes as a public health measure have been established in Switzerland since 1999, starting in the cantons of Geneva, Lausanne and Valais [14] . These screening programmes were initiated on the basis of evidence from the literature, but also evaluations of systematic screening programmes in countries such as Sweden and The Netherlands [19, 20] . Potential advantages of systematic programmes over individualised opportunistic screening include better information of women about the possible benefits and harms of screening, quality control of mammography and monitoring of the diagnostic workup of suspicious mammography findings [6] . Another important advantage is that organised screening programmes in principle ensure equal access for all women. In our study, lower education level was not associated with lower participation in breast cancer screening, in contrast to a previous study using the SHIS data of 2002 [10] . This could suggest that inequities in access may have levelled off. On the other hand, women attending other cancer screening programmes and women with a private hospital stay insurance, had a higher uptake of mammography, possibly reflecting individuals with a higher health awareness [10] . In Switzerland, uptake of breast cancer screening was higher in regions with long-standing screening programmes, lower in regions where screening programmes have been recently introduced, and lowest in regions where no programme exists. Eleven cantonal screening programmes had been established up to 2012, the time of the latest survey, and these programmes covered 37% of the eligible population [14] . The regions with long-standing screening programmes correspond to the French-speaking area of the country, where a high uptake has previously been demonstrated [8, 9] , whereas opportunistic screening dominates in the German-speaking area. This difference did not seem to be influenced by sociodemographic or health-related factors [9] , but appears to be driven by public promotion of screening, recommendations by healthcare providers, and cultural factors, including different beliefs and attitudes. Interestingly, the decrease in the use of mammography observed in our study was more pronounced in regions with a generally higher uptake. Despite the drop in self-reported mammography screening, breast cancer mortality in Switzerland continues to decrease, probably because of improvements in treatment, as well as changes in cause-of-death coding [1, 6] . Our study is limited by the fact that self-reported mammography may not reflect the number of screened women, and the distinction between opportunistic, programmatic and diagnostic mammography might not always be accurate. However, a study from Israel showed reasonable agreement between self-reported and registered mammography [21] , and a study of post-treatment mammography surveillance showed a high congruence, particularly for results in the past 7 to 12 months [22] . Moreover, a validation study from colon cancer screening also showed a good agreement between self-reporting and patient charts [23] . Finally, the SHIS is a nationwide, representative survey, and analyses were weighted and adjusted for a wide range of important sociodemographic and health-related factors.
In conclusion, uptake of breast cancer screening is low in Swiss women and decreased between 2007 and 2012. Many factors may have contributed to this decline. The ongoing debates on the usefulness of screening programmes in Switzerland [4, 7, 24, 25] and the limited evidence for breast cancer mortality reduction by screening [6] , especially when uptake of mammography is low, are likely to have influenced the trend in mammography attendance and the public willingness to accept screening tests in Switzer-land. The next survey round of 2017 (data available end of 2018) might show further trends. Future surveys should include additional questions to better distinguish between diagnostic, opportunistic, and programmatic mammography, as well as questions on the willingness to participate in screening programs. Our findings should be taken into consideration for future adaption of public information and implementation of cancer screening programs such as systematic screening for colorectal cancers with substantial and long-lasting benefits [26] [27] [28] .
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